Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Livzon Pharmaceutical Group ( (HK:1513) ) has provided an update.
Livzon Pharmaceutical Group Inc. has announced the current positions held by its board of directors and the composition of its board committees. This announcement provides insights into the leadership structure of the company, which could impact its strategic direction and governance. The board includes a mix of executive, non-executive, and independent directors, with various members chairing key committees such as the Audit Committee and the Environmental, Social and Governance Committee. This structure reflects the company’s focus on robust governance and strategic oversight, potentially influencing its market positioning and stakeholder confidence.
The most recent analyst rating on (HK:1513) stock is a Sell with a HK$37.23 price target. To see the full list of analyst forecasts on Livzon Pharmaceutical Group stock, see the HK:1513 Stock Forecast page.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is based in Zhuhai, China, and is known for its commitment to innovation and quality in the healthcare sector.
Average Trading Volume: 860,760
Technical Sentiment Signal: Hold
Current Market Cap: HK$33.01B
Find detailed analytics on 1513 stock on TipRanks’ Stock Analysis page.